SEC ownership of Abivax S.A.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001956827.

Comparable stake leader

TCG Crossover GP I, LLC

Disclosed value leader

TCG Crossover Management, LLC

Comparable rows

50/50

Latest evidence

02 Jul 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
TCG Crossover GP I, LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
02 Jul 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001956827
Issuer location
Paris

Ownership snapshot

Top shareholders of Abivax S.A. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
TCG Crossover GP I, LLC
Disclosed value leader
TCG Crossover Management,...
Comparable rows
50/50
Latest evidence
02 Jul 2026
13D/G 13F Lead comparable stake: 9.1% 13D/G row: TCG Crossover GP I, LLC Showing 1-8 of 50 holder rows.

Quick read

TCG Crossover GP I, LLC leads the comparable SEC ownership view at 9.1%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TCG Crossover GP I, LLC's linked filing trail.
Comparable ownership Top 5
TCG Crossover GP I, LLC 9.1%
Invus Global Management, LLC 5%
Deep Track Capital, LP 4.8%
Sofinnova Crossover I 4.3%
Venrock Healthcare Capital Partne... 0.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
TCG Crossover GP I, LLC
13D/G
Chen Yu
9.1%
$603,774,500
7,111,596 shares
$0 30 Sep 2025
Invus Global Management, LLC
13D/G
Invus Public Equities, L.P.
5%
$469,347,122
3,922,995 shares
-$177,185,644 31 Dec 2025
Deep Track Capital, LP
13D/G
4.8%
$28,885,195
3,480,144 shares
$0 30 Jun 2025
Sofinnova Crossover I
13D/G
Sofinnova Crossover I SLP
4.3%
$471,190,328
3,535,843 shares
-$261,676,160 02 Jul 2026
Venrock Healthcare Capital Partners III, L.P.
13D/G
0.8%
$48,964,292
576,729 shares
$0 30 Sep 2025
TCG Crossover Management, LLC
13F
Company
13F
7.9%
$721,668,815
6,481,085 shares
31 Mar 2026
UBS Group AG
13F
Company
13F
5.5%
$506,353,658
4,547,406 shares
31 Mar 2026
Darwin Global Management, Ltd.
13F
Company
13F
4.2%
$352,068,686
3,468,657 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 Jul 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for Abivax S.A.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .